|
|
|
|
In this ongoing, open-label Phase II study, 60 biomarker-unselected, treatment-naive patients with resectable NSCLC were randomized to receive two preoperative doses of nivolumab with or without relatlimab antibody therapy. [Nature Medicine]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Scientists presented prime editing approaches to correct L227R- and N1303K-CFTR, two mutations that caused cystic fibrosis and were not eligible for current market-approved modulator therapies. [Cell Reports Medicine]
|
|
|
|
|
|
The authors demonstrated that loss of the Mirlet7b/Mirlet7c2 cluster in T cells predisposed mice to exaggerated cigarette smoke- or nanosized carbon black-elicited emphysema.
[eLife]
|
|
|
|
|
|
Investigators observed a significant increase in iron concentration during acute lung injury, accompanied by elevated levels of lipid peroxidation markers such as malonaldehyde and 4-hydroxynonenal.
[Inflammation]
|
|
|
|
|
|
|
|
Researchers integrated studies in patient-derived and immunocompetent lung cancer models and clinical specimens obtained from patients on targeted therapy to uncover a focal adhesion kinase-YAP signaling axis that promoted residual disease during oncogenic EGFR-, ALK-, and KRAS-targeted therapies. [Nature Communications]
|
|
|
|
|
|
The authors presented the development and validation of lung tumor-on-chip platforms to quickly and precisely measure ex vivo the effects of immune checkpoint inhibitors on T cell-mediated cancer cell death by exploiting the power of live imaging and advanced image analysis algorithms.
[Cell Reports Medicine]
|
|
|
|
|
|
Investigators observed that deletion of Nek10 in lung adenocarcinoma cells resulted in dramatic stabilization of β-catenin, suggestive of a Nek10 role in the control of β-catenin turnover.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]
|
|
|
|
|
|
Researchers identified the oncogenic protein annexin 2 (ANXA2) as a potential interacting patterner of highly accelerated region 1A (HAR1A). HAR1A overexpression enhanced ANXA2 ubiquitination and accelerated its degradation via the ubiquitin–proteasome pathway.
[Cell Death Discovery]
|
|
|
|
|
|
Integrative analyses of multiple-omics data revealed that high mobility group nucleosome binding (HMGN) frequently exhibited dysregulation in lung adenocarcinoma. [Scientific Reports]
|
|
|
|
|
|
|
|
Scientists summarize how the gut-lung axis influences COPD, including the alterations of intestinal microecology, the pathological mechanisms, and the involved immune responses. [Heliyon]
|
|
|
|
|
|
|
|
Based on the ALINA trial results, the FDA approved alectinib as adjuvant therapy for people with ALK-positive NSCLC. [National Cancer Institute]
|
|
|
|
|
|
|
|
May 20, 2024 New York, New York, United States & Online
|
|
|
|
|
|
|
|
|
|
|
University of Utrecht – Utrecht, Netherlands
|
|
|
|
|
|
|
St. Jude Children’s Research Hospital – Memphis, Tennessee, United States
|
|
|
|
|
|
|
Indiana University School of Medicine – Indianapolis, Indiana, United States
|
|
|
|
|
|
|
Brigham and Women’s Hospital – Boston, Massachusetts, United States
|
|
|
|
|
|
|
University of Texas Health Science Center – Houston, Texas, United States
|
|
|
|
|
|